• 中国核心期刊(遴选)数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

中国药物评价 ›› 2019, Vol. 36 ›› Issue (6): 452-454.

• 药品评价-临床研究 • 上一篇    下一篇

帕拉米韦在儿童甲型流行性感冒中的疗效观察

唐亮1,占诗贵2   

  1. 1. 东莞市滨海湾中心医院儿科
    2. 东莞市滨海湾中心医院
  • 收稿日期:2020-01-19 出版日期:2019-12-28 发布日期:2020-01-21

Observation on the Curative Effect of Peramivir with Influenza A in Children

  • Received:2020-01-19 Online:2019-12-28 Published:2020-01-21

摘要: 目的:探讨帕拉米韦在儿童甲型流感中的治疗效果,为临床合理选用抗流感病毒药物提供参考。方法:回顾性分析我院儿科2017年6月至2019年3月收治的甲型流感病例资料,比较帕拉米韦与奥司他韦治疗儿童甲型流感的发热缓解时间及住院时间,比较不同年龄组(≥36月龄和<36月龄)患儿应用帕拉米韦治疗甲型流感的发热缓解时间、用药剂次及住院时间。结果:帕拉米韦与奥司他韦治疗儿童甲型流感的发热缓解时间、住院时间相比差异无统计学意义(P>0.05),≥36月龄组和<36月龄组甲型流感患儿应用帕拉米韦治疗后在发热缓解时间、用药剂次及住院时间上比较差异均无统计学意义(P>0.05)。结论:帕拉米韦和奥司他韦对儿童单纯性甲型流感均有较好疗效,帕拉米韦为不能接受口服药物治疗者提供了选择。

Abstract: Objective:To explore the therapeutic effect of peramivir in children with influenza A, and to provide reference for clinical rational selection of anti-influenza virus drugs. Methods:Retrospective analysis of the influenza A case data from the pediatric department of Hospital from June 2007 to March 2009. The fever remission time and the hospitalization time of the influenza A in children treated with peramivir and oseltamivir are compared. And the fever remission time, medication times and hospitalization time of different age groups (≥36 months and <36 months) are compared. Results:There was no significant difference in fever remission time and hospitalization time between peramivir and oseltamivir in children with influenza A (P>0.05). And there was no significant difference in fever remission time, medication times and hospitalization time between ≥36 months group and<36 months group (P>0.05). Conclusion:Peramivir and oseltamivir are effective in the treatment of simple influenza A in children. Peramivir provides a choice for those who can not receive oral medication.

中图分类号: